Price
No data yet.
Social Signal Score
Analyst Ratings
Revenue
$239.0K+267.69%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Doron Robert Besser
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Employees
- 13
- Beta
- 1.56
- Country
- US
- Piotroski score
- 1 / 9 (Weak)
- Altman Z-score
- -5.82
Financials
Revenue
$239.0K+267.7%Net Income
$-4.90MEBITDA
$-5.25MFree Cash Flow
$-2.72MEPS (diluted)
$-23.76Shares Outstanding (diluted)
513.1K+294787.4%Operating Expenses
$5.21MCash & Debt
$1.14MReturn of Capital
$1.48MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.55M | $-18.18M | $-234.48 |
| 2024 | $2.56M | $-3.71M | $-1647.60 |
| 2023 | $2.28M | $-3.71M | $-2799.00 |
| 2022 | $752.0K | $-5.45M | $-5065.68 |
| 2021 | $1.70M | $-14.28M | $-14984.16 |
| 2020 | $623.0K | $-4.33M | $-11087.52 |
| 2019 | $530.0K | $-5.79M | $-22042.68 |
| 2018 | $318.0K | $-4.15M | $-17006.88 |
| 2017 | $239.0K | $-5.81M | $-30888.00 |
| 2016 | $229.0K | $-2.83M | $-16368.00 |
| 2015 | $147.0K | $-2.88M | $-38544.00 |
| 2014 | $203.0K | $-2.65M | $-15315.96 |
| 2013 | $211.0K | $-1.99M | $-11508.84 |
| 2012 | $166.0K | $-1.27M | $-7377.48 |
Valuation
FEEDhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+25.00%Social Signal Score
Mentions (3)
- Newsglobenewswire.com·34d ago·Neutral
…ical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange TYLER, Texas, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced it has been selected to exhibit its ENvue™ Navigation Platform, a minimally invasive electromagnetic navigation system guiding feeding tube placement, at the Vizient® Innovative Tech…
View source ↗ - Newsglobenewswire.com·49d ago·Neutral
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million Multi-year agreement with Peak Medical expands UroShield commercialization across the United Kingdom and Republic of Ireland Multi-year agreement with Peak Medical expands UroShield commercialization across the United Kingdom and Republic of Ireland
View source ↗ - Newsglobenewswire.com·55d ago·Negative
ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions TYLER, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that it has entered into a securities purchase agreement (“ELOC”) with an institutional investor providing the Company with an equity facility for up to $50 million in capital (th
View source ↗
Earnings
Tue, Nov 17(in 6 weeks)
Estimates and results for FEED via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by FEED officers and directors.
- Bought
- $729k
- Sold
- $109k
2 trades
32 trades
- Bank Of America Corp /de/sold
- Bank Of America Corp /de/sold
- Bank Of America Corp /de/sold
- Bank Of America Corp /de/sold
- Bank Of America Corp /de/sold
- Bank Of America Corp /de/sold
- Bank Of America Corp /de/sold
- Bank Of America Corp /de/sold
21 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in FEED.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.